6jh1
From Proteopedia
(Difference between revisions)
m (Protected "6jh1" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Crystal structure of bISG15/NS1B complex== | |
| - | + | <StructureSection load='6jh1' size='340' side='right'caption='[[6jh1]], [[Resolution|resolution]] 3.00Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[6jh1]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6JH1 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6JH1 FirstGlance]. <br> | |
| - | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6jh1 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6jh1 OCA], [http://pdbe.org/6jh1 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6jh1 RCSB], [http://www.ebi.ac.uk/pdbsum/6jh1 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6jh1 ProSAT]</span></td></tr> | |
| - | [[Category: | + | </table> |
| - | [[Category: Jiang, Y | + | == Function == |
| - | [[Category: Wang, X | + | [[http://www.uniprot.org/uniprot/NS1_INBLE NS1_INBLE]] Binds and inhibits the ubiquitin-like protein G1P2/ISG15, which is an early antiviral protein. Inhibits IRF-3 nuclear translocation and activation. Inhibits IFN-beta promoter activation; this inhibition is not dsRNA-binding dependent Prevents EIF2AK2/PKR activation, either by binding double strand RNA or by interacting directly with EIF2AK2/PKR. Also binds poly(A) and U6 snRNA. Suppresses the RNA silencing-based antiviral response in Drosophila cells.<ref>PMID:15479798</ref> [[http://www.uniprot.org/uniprot/ISG15_BOVIN ISG15_BOVIN]] Ubiquitin-like protein which plays a key role in the innate immune response to viral infection either via its conjugation to a target protein (ISGylation) or via its action as a free or unconjugated protein. ISGylation involves a cascade of enzymatic reactions involving E1, E2, and E3 enzymes which catalyze the conjugation of ISG15 to a lysine residue in the target protein. Exhibits antiviral activity towards both DNA and RNA viruses. The secreted form of ISG15 can: induce natural killer cell proliferation, augment lymphokine-activated-killer (LAK) activity, induce dendritic cell maturation, act as a chemotactic factor for neutrophils and act as a IFN-gamma-inducing cytokine playing an essential role in antimycobacterial immunity (By similarity). The secreted form acts through the integrin ITGAL/ITGB2 receptor to initiate activation of SRC family tyrosine kinases including LYN, HCK and FGR which leads to secretion of IFNG and IL10; the interaction is mediated by ITGAL (By similarity). In response to IFN-tau secreted by the conceptus, may ligate to and regulate proteins involved in the release of prostaglandin F2-alpha (PGF), and thus prevent lysis of the corpus luteum and maintain the pregnancy (PubMed:9546718).[UniProtKB:P05161][UniProtKB:Q64339]<ref>PMID:9546718</ref> |
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Jiang, Y N]] | ||
| + | [[Category: Wang, X W]] | ||
| + | [[Category: Antiviral protein]] | ||
| + | [[Category: Antivral]] | ||
| + | [[Category: Complex]] | ||
Revision as of 05:51, 16 October 2019
Crystal structure of bISG15/NS1B complex
| |||||||||||
